INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 423m ago
House PTR23m ago
SEC 13F22m ago
Robinhood Chain22m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

65,929 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
WE
Waltz William E Jr.Director, President and CEO
ATKRAtkore Inc.
Disposition to issuer
D—
219.5K sh
Oct 19, 2026Oct 21, 2026
Page 144 of 1649
← PrevNext →
traded Oct 19, 2026
+2d
SEC Form 4

Evidence

9
VA
Vorsheck Elizabeth ADirector, 10% Owner
ERIEERIE INDEMNITY CO
Grant or award
A—
88 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

9
GR
Grant Jay RChief Legal Officer
TTDTrade Desk, Inc.
Grant or award
A—
120.5K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

9
VL
Valdez Arthur L JrDirector
PIIMPINJ INC
Option exercise
M—
1,220 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

9
JR
Jaramillo Mejia RicardoDirector
CIBGrupo Cibest S.A.
Grant or award
A$2,417
245 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

9
WD
Woods DavidChief Commercial Officer
PLSMPulsenmore Ltd.
Grant or award
A—
6,886 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

9
CE
Capers Julien E.See Remarks
PALIPALISADE BIO, INC.
Grant or award
A—
787.3K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

9
VA
von Bayern AnnaChief Corp. Affairs Officer
COTYCOTY INC.
Option exercise
M—
6,105 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

9
LW
Lowe LeAngela W.VP, Chief HR Officer
ATKRAtkore Inc.
Disposition to issuer
D—
3,963 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

9
KS
Kelly Daniel SVP, General Counsel and Sec.
ATKRAtkore Inc.
Disposition to issuer
D—
8,484 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

9
KS
Kelly Daniel SVP, General Counsel and Sec.
ATKRAtkore Inc.
Disposition to issuer
D—
8,897 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

8
KH
Khan Salman HassanChief Financial Officer
MARAMARA Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$126K
16.0K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

8
WK
Walsh KeithEVP and CFO
AIGAMERICAN INTERNATIONAL GROUP, INC.
Tax withholding
F$56K
688 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
160 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

8
BW
Baumgartner Jeffrey WEVP, R&D
CRUSCIRRUS LOGIC, INC.
Open-market sale · 10b5-1 plan
SELL$126K
1,166 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
59 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

8
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$189K
14.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

8
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
320 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

7
SS
Sijbrandij SytseDirector
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$2.29M
42.7K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

7
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$1.11M
13.8K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

7
SS
Sijbrandij SytseDirector
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$3.90M
73.5K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

6
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$61K
14.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

6
PJ
Prahm JeremyChief Investment Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$60K
5,610 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
LF
Lamps Mark F.Pres. Safety & Infrastructure
ATKRAtkore Inc.
Disposition to issuer
D—
12.1K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$9,197
115 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
LF
Lamps Mark F.Pres. Safety & Infrastructure
ATKRAtkore Inc.
Disposition to issuer
D—
3,505 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
LF
Lamps Mark F.Pres. Safety & Infrastructure
ATKRAtkore Inc.
Disposition to issuer
D—
4,162 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
LF
Lamps Mark F.Pres. Safety & Infrastructure
ATKRAtkore Inc.
Disposition to issuer
D—
8,897 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
2,869 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

4
AH
Anderson David HugoDirector
NWNNorthwest Natural Holding Co
Open-market sale · 10b5-1 plan
SELL$73K
1,500 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$920K
11.5K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

4
PG
Patel Rahul G.Director, See remarks below
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$506K
4,302 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$191K
2,388 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$2,485
100 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

3
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
14.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

3
GA
Garefis AmyEVP, Chief People Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$36K
7,879 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$151K
5,999 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

1
GN
Ghamsari NimaDirector, HEAD OF BLEND
BLNDBlend Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
27.8K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

1
MK
Malady KyleEVP and Group CEO-VZ Business
VZVERIZON COMMUNICATIONS INC
Open-market sale · 10b5-1 plan
SELL$49K
1,100 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$150K
5,882 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence